FBIO
Fortress Biotech Inc
NASDAQ: FBIO · HEALTHCARE · BIOTECHNOLOGY
$2.30
+3.60% today
Updated 2026-04-30
Market cap
$75.03M
P/E ratio
—
P/S ratio
1.19x
EPS (TTM)
$-0.07
Dividend yield
—
52W range
$2 – $5
Volume
0.8M
Fortress Biotech Inc (FBIO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-3.0%
Last 4 quarters
Revenue YoY growth
+6.3%
Most recent quarter
EPS YoY growth
+29.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+8.7%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+12.6%
2025-12-31
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.21 | -290.9% | $3.58 | $4.03 | +12.6% |
| 2025-11-14 | $0.11 | +1200.0% | $2.49 | $2.61 | +4.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.11 | $-0.21 | -290.9% | $16.07M | +6.3% |
| 2025-09-30 | $-0.01 | $0.11 | +1200.0% | $17.63M | +20.5% |
| 2025-06-30 | $0.07 | $0.45 | +542.9% | $16.41M | +10.2% |
| 2025-03-31 | $-0.44 | $-0.48 | -9.1% | $13.14M | +0.8% |
| 2024-12-31 | $-0.75 | $-0.30 | +60.1% | $15.12M | -24.2% |
| 2024-09-30 | $-0.27 | $-0.76 | -181.5% | $14.63M | -57.9% |
| 2024-06-30 | $-1.22 | $-0.73 | +40.2% | $14.90M | -14.3% |
| 2024-03-31 | $-1.73 | $-1.03 | +40.5% | $13.03M | +4.8% |
| 2023-12-31 | $-1.97 | $-1.28 | +35.0% | $19.95M | — |
| 2023-09-30 | $-3.21 | $-0.94 | +70.7% | $34.75M | — |
| 2023-06-30 | $-0.23 | $-0.24 | -4.3% | $17.39M | — |
| 2023-03-31 | $-0.20 | $-0.21 | -5.0% | $12.43M | — |
Frequently asked questions
Has Fortress Biotech Inc beaten earnings estimates?
Fortress Biotech Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -3.0% over the last 3 quarters.
How does FBIO stock react to earnings?
FBIO stock has moved an average of +8.7% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Fortress Biotech Inc's revenue growth rate?
Fortress Biotech Inc reported year-over-year revenue growth of +6.3% in its most recent quarter, with EPS growing +29.8% year-over-year.